drugset / Trial / NCT03043196

1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis

NCT03043196

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the present study was to evaluate the effects of subgingival delivery of Rosuvastatin gel as an adjunct to scaling and root planing in Smokers With Chronic Periodontitis (CP) patients.

Timeline

Start
2015-06
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosuvastatin Small molecule 1.2 % Other

Indications